ABBV

Q: What is the price of AbbVie (ABBV) today?

The price of AbbVie (ABBV) today is R$ 1.131,39, with a variation of 9.31% compared to the last year. The price of AbbVie (ABBV) started the year trading around R$ 964,91 and today it is at R$ 1.131,39. Follow the real-time price chart, the historical price of AbbVie (ABBV), and stock data from Ibovespa and international markets.

Q: When does AbbVie (ABBV) pay dividends?

AbbVie (ABBV) distributed dividends in the last year,in the months of February, May, August e November totaling R$ 33,67. The Dividend Yield for the last 12 months is 3,38%.

Q: AbbVie (ABBV) is it worth it?

Currently, AbbVie (ABBV) is priced at R$ 1.131,39, with a P/E of 79,66%, representing a deviation of 48,98% from its historical average P/E. In the last year, the stock showed a variation of 9.31% in its price and distributed R$ 33,67 in dividends, resulting in a Dividend Yield of 3,38%. The total shareholder return was 9,31%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of AbbVie (ABBV)?

Investing in shares of AbbVie (ABBV) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of AbbVie (ABBV) yield today?

The yield of AbbVie (ABBV) was 10,45% in the last month, 9,31% in the last year and 171,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 35,13 in dividends, um Dividend Yield de 3,38%.If you wanted to buy 100 shares of AbbVie (ABBV) today, the total investment would be based on the current price of R$ 1.131,39.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 123.672,77In 5 years: R$ 306.607,99In 10 years: 574.952,21It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

AbbVie Inc.

Price

US$ 208,36

variation (12m)

9,31%

p/l

79,66

p/vp

228,58

DIVIDEND YIELD

3,38%

quote ABBV

BVMF

ABBV

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of ABBV

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

10,45%

3 months

14,78%

1 year

9,31%

2 years

52,11%

5 years

171,00%

10 years

408,18%

real profitability

profitability minus inflation.

1 month

10,45%

3 months

14,21%

1 year

3,86%

2 years

38,65%

5 years

98,02%

10 years

201,27%

Indicators ABBV

check out the fundamentals of AbbVie shares

P/L

79,66

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

5,83

Sector: -3,71 Industry: -3,71

P/VP

228,58

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

3,38%

Sector: - Industry: -

ROA

3,08%

Sector: -63,89% Industry: -63,89%

ROE

286,94%

Sector: -67,90% Industry: -67,90%

ROIC

10,73%

Sector: -2.087,71% Industry: -2.087,71%

Net Margin

7,31%

Sector: -43,60% Industry: -43,60%

GROSS MARGIN

70,69%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

22,51%

Sector: -43,47% Industry: -43,47%

P/EBITDA

22,55

Sector: -3,14 Industry: -3,14

P/EBIT

51,65

Sector: -3,42 Industry: -3,42

P/ASSETS

2,45

Sector: 1,29 Industry: 1,29

VPA

0,83

Sector: 1,78 Industry: 1,78

LPA

2,37

Sector: -2,10 Industry: -2,10

EQUITY / ASSETS

0,01

Sector: 0,41 Industry: 0,41

CAGR REVENUES 5 YEARS

4,60%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-1,89%

Sector: - Industry: -

FAIR PRICE OF AbbVie ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 208,36

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-96,81%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

ABBV indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%
HRMY	11,93	2,79	23,40%	0,00%	US$ 2,16 B	23,42%

comparison of ABBV with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history ABBV dividend history

Current DY: 3,38%

5-year average DY: 4,22%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	15/07/2025	15/08/2025	1,64000000
Dividends	15/04/2025	15/05/2025	1,64000000
Dividends	15/01/2025	14/02/2025	1,64000000
Dividends	15/10/2024	15/11/2024	1,55000000
Dividends	15/07/2024	15/08/2024	1,55000000
Dividends	15/04/2024	15/05/2024	1,55000000
Dividends	16/01/2024	15/02/2024	1,55000000
Dividends	13/10/2023	15/11/2023	1,48000000
Dividends	14/07/2023	15/08/2023	1,48000000
Dividends	14/04/2023	15/05/2023	1,48000000
Dividends	13/01/2023	15/02/2023	1,48000000
Dividends	14/10/2022	15/11/2022	1,41000000
Dividends	15/07/2022	15/08/2022	1,41000000
Dividends	15/04/2022	16/05/2022	1,41000000
Dividends	14/01/2022	15/02/2022	1,41000000
Dividends	15/10/2021	15/11/2021	1,30000000
Dividends	15/07/2021	16/08/2021	1,30000000
Dividends	15/04/2021	14/05/2021	1,30000000
Dividends	15/01/2021	16/02/2021	1,30000000
Dividends	15/10/2020	16/11/2020	1,18000000
Dividends	15/07/2020	14/08/2020	1,18000000
Dividends	15/04/2020	15/05/2020	1,18000000
Dividends	15/01/2020	14/02/2020	1,18000000
Dividends	15/10/2019	15/11/2019	1,07000000
Dividends	15/07/2019	15/08/2019	1,07000000
Dividends	15/04/2019	15/05/2019	1,07000000
Dividends	15/01/2019	15/02/2019	1,07000000
Dividends	15/10/2018	15/11/2018	0,96000000
Dividends	13/07/2018	15/08/2018	0,96000000
Dividends	13/04/2018	15/05/2018	0,96000000
Dividends	12/01/2018	15/02/2018	0,71000000
Dividends	13/10/2017	15/11/2017	0,64000000
Dividends	14/07/2017	15/08/2017	0,64000000
Dividends	13/04/2017	15/05/2017	0,64000000
Dividends	13/01/2017	15/02/2017	0,64000000
Dividends	14/10/2016	15/11/2016	0,57000000
Dividends	15/07/2016	15/08/2016	0,57000000
Dividends	15/04/2016	16/05/2016	0,57000000
Dividends	15/01/2016	16/02/2016	0,57000000
Dividends	15/10/2015	16/11/2015	0,51000000
Dividends	15/07/2015	14/08/2015	0,51000000
Dividends	15/04/2015	15/05/2015	0,51000000
Dividends	15/01/2015	13/02/2015	0,49000000
Dividends	15/10/2014	17/11/2014	0,42000000
Dividends	15/07/2014	15/08/2014	0,42000000
Dividends	15/04/2014	15/05/2014	0,42000000
Dividends	15/01/2014	14/02/2014	0,40000000
Dividends	15/10/2013	15/11/2013	0,40000000
Dividends	15/07/2013	15/08/2013	0,40000000
Dividends	15/04/2013	15/05/2013	0,40000000
Dividends	15/01/2013	15/02/2013	0,40000000

ABOUT THE COMPANY AbbVie

AbbVie Inc.

Average user rating I10

5.0 (577 people)

Estados Unidos

13 years

Foundation: 2012

2012

Year of debut on the stock exchange - 13 years

47.000

Employees

Additional Information

The Company AbbVie Inc. (Estados Unidos), is listed on NYSE with a market value of $ 334,19 Billions, having a net worth of $ 1,46 Billion.

With a total of 47.000 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 57,37 Billions, which generated a profit in the amount of $ 4,20 Billions.

As for its main indicators, the Company has a P/E ratio of 79,66, a P/B ratio of 228,58 and in the last 12 months the dividend yield of ABBV was at 3,38%.

The Company is traded in Brazil through the BDR ABBV34, or can be purchased on abroad through the ticker ABBV.

Market value

US$ 334,19 Billions

Net worth

US$ 1,46 Billion

US$ 1.462.000.000,00

Assets

US$ 136,17 Billions

US$ 136.165.000.000,00

Total Number of Shares

1,77 Billion

1.768.000.000

Average Daily Trading Volume

US$ 5,90 Milhões

US$ 5.899.163,20

Sector

Cuidados de saúde

Industry

Biotecnologia

ABBV

ABBV revenue and profits

ABBV results

DRAG THE FRAME TO SEE MORE DATA

ABBV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 25,01% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 37,15% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 11,52% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,70% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,03% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

BMY - Bristol-Myers Squibb

US$ 47,21 2,47% (12M)

P/L

19,31

5,13%

ROE

28,87%

P/VP

5,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 25,01% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 37,15% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 11,52% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,70% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,03% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

BMY - Bristol-Myers Squibb

US$ 47,21 2,47% (12 M)

P/L

19,31

5,13%

ROE

28,87%

P/VP

5,58

Common Questions

What is the price of AbbVie (ABBV) today?

The price of AbbVie (ABBV) today is R$ 1.131,39, with a variation of 9.31% compared to the last year. The price of AbbVie (ABBV) started the year trading around R$ 964,91 and today it is at R$ 1.131,39. Follow the real-time price chart, the historical price of AbbVie (ABBV), and stock data from Ibovespa and international markets.

When does AbbVie (ABBV) pay dividends?

AbbVie (ABBV) distributed dividends in the last year,in the months of February, May, August e November totaling R$ 33,67. The Dividend Yield for the last 12 months is 3,38%.

AbbVie (ABBV) is it worth it?

Currently, AbbVie (ABBV) is priced at R$ 1.131,39, with a P/E of 79,66%, representing a deviation of 48,98% from its historical average P/E. In the last year, the stock showed a variation of 9.31% in its price and distributed R$ 33,67 in dividends, resulting in a Dividend Yield of 3,38%. The total shareholder return was 9,31%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of AbbVie (ABBV)?

Investing in shares of AbbVie (ABBV) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of AbbVie (ABBV) yield today?

The yield of AbbVie (ABBV) was 10,45% in the last month, 9,31% in the last year and 171,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 35,13 in dividends, um Dividend Yield de 3,38%.

If you wanted to buy 100 shares of AbbVie (ABBV) today, the total investment would be based on the current price of R$ 1.131,39.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 123.672,77
In 5 years: R$ 306.607,99
In 10 years: 574.952,21

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ABBV

AbbVie Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of ABBV

check out the fundamentals of AbbVie shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years a year ago, today you would have

Current DY: 3,38%

5-year average DY: 4,22%

type

date with

payment date

value

ABOUT THE COMPANY AbbVie

AbbVie Inc.

Estados Unidos

13 years

2012

47.000

Additional Information

PROFIT X PRICE ABBV

ABBV results

ABBV cash flow

evolution of assets - ABBV

ABBV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80